Identification of features and differences in PD-1 inhibitor-associated myocarditis and acute myocardial infarction using proteomic analysis: a clinical and preclinical study
Biochemistry and Cell Biology · 2025
DOI: 10.1139/bcb-2025-0170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2025. Verfasst von Yuxi Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province 330006, China. Hauptthemen laut MEDLINE: Myocarditis, Myocardial Infarction, Proteomics, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Foundation of Jiangxi Educational.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs)-related myocarditis, a severe complication characterized by elevated cardiac troponin I, poses significant clinical challenges in distinguishing it from acute myocardial infarction (AMI). Our study aimed to identify plasma protein biomarkers that differentiate ICIs-myocarditis from AMI. Plasma samples from 5 ICIs-myocarditis patients (with paired baseline and diagnosis samples) and 5 angiography-confirmed AMI patients, matched for age, gender, smoking history, and pre-existing heart disease, were analyzed using label-free liquid chromatography-mass spectrometry proteomics. A total of 1521 plasma proteins were identified, with 1325 quantifiable. Proteomic profiling revealed differentially expressed proteins (DEPs) in ICIs-myocarditis associated with myocardial contraction, proteasome activity, NF-κB signaling, immunoregulation, and amino acid metabolism. Through validation in animal models of ICIs-myocarditis and AMI, two plasma proteins—MYOM3 (myomesin 3) and galectin-1 (LGALS1)—were identified as potential biomarkers linked to the onset of ICIs-related myocarditis. Further validation using expanded clinical cohorts confirmed their differential expression. These findings highlight MYOM3 and galectin-1 as promising biomarkers for distinguishing ICIs-related myocarditis from AMI, providing insights for clinical diagnosis and mechanistic research into immune-related cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province 330006, China.
- Jiangxi Province Key Laboratory of Immunology and Inflammation, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province 330006, China.
- Radiation Induced Heart Damage Institute, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province 330006, China.
- Second Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province 330006, China.
- Department of Cardiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province 330006, China.
ORCID-Profile: Zhimin Zeng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Foundation of Jiangxi Educational
- Foundation of Jiangxi Provincial Health
Zitieren
APA
Luo, Y., Yi, Y., Zeng, F., Lu, Z., Xu, W., Fang, H., Xu, P., Liu, A., & Zeng, Z. (2025). Identification of features and differences in PD-1 inhibitor-associated myocarditis and acute myocardial infarction using proteomic analysis: a clinical and preclinical study. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2025-0170
Vancouver
Luo Y, Yi Y, Zeng F, Lu Z, Xu W, Fang H, et al. Identification of features and differences in PD-1 inhibitor-associated myocarditis and acute myocardial infarction using proteomic analysis: a clinical and preclinical study. Biochemistry and Cell Biology. 2025. doi:10.1139/bcb-2025-0170
BibTeX
@article{Luo2025,
author = {Luo, Yuxi and Yi, Yali and Zeng, Fujuan and Lu, Zhiqin and Xu, Wenjie and Fang, Haiyang and Xu, Peng and Liu, Anwen and Zeng, Zhimin},
title = {Identification of features and differences in PD-1 inhibitor-associated myocarditis and acute myocardial infarction using proteomic analysis: a clinical and preclinical study},
journal = {Biochemistry and Cell Biology},
year = {2025},
doi = {10.1139/bcb-2025-0170}
}
EUVIMED